[1] |
Levy MM, Evans LE, Rhodes A. The surviving sepsis campaign bundle: 2018 update. Intensive Care Med, 2018; 44, 925−8. doi: 10.1007/s00134-018-5085-0 |
[2] |
Kacmarek RM, Villar J. Lung recruitment maneuvers during acute respiratory distress syndrome: is it useful?. Minerva Anestesiol, 2011; 77, 85−9. |
[3] |
Emergency Medicine Branch of Chinese Medical Association, Emergency Physicians Branch of Chinese Medical Association, Emergency Medicine Professional Committee of Chinese People's Liberation Army, et al. Expert consensus on emergency treatment of sepsis fluid. Chin J Emerg Med, 2018; 27, 30−8. (In Chinese |
[4] |
Raghunathan K, Nailer P, Konoske R. What is the ideal crystalloid?. Curr Opin Crit Care, 2015; 21, 309−14. doi: 10.1097/MCC.0000000000000218 |
[5] |
ProCESS Investigators, Yealy DM, Kellum JA, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med, 2014; 370, 1683−93. doi: 10.1056/NEJMoa1401602 |
[6] |
ARISE Investigators, ANZICS Clinical Trials Group, Peake SL, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med, 2014; 371, 1496−506. doi: 10.1056/NEJMoa1404380 |
[7] |
Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0. 42 versus ringer's acetate in severe sepsis. N Engl J Med, 2012; 367, 124−34. |
[8] |
Laterre PF, Berry SM, Blemings A, et al. Effect of selepressin vs placebo on ventilator- and vasopressor-free days in patients with septic shock: the SEPSIS-ACT randomized clinical trial. JAMA, 2019; 322, 1476−85. doi: 10.1001/jama.2019.14607 |
[9] |
Adhikari NKJ, Fowler RA, Bhagwanjee S, et al. Critical care and the global burden of critical illness in adults. Lancet, 2010; 376, 1339−46. doi: 10.1016/S0140-6736(10)60446-1 |
[10] |
Fleischmann C, Scherag A, Adhikari NKJ, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med, 2016; 193, 259−72. doi: 10.1164/rccm.201504-0781OC |